As if the U.S. Food and Drug Administration (FDA) wasn’t upsetting non-GMO activists enough already with its approvals of GM crops, it may now approve genetically modified mosquitoes from British biotech firm Oxitec. The goal is to combat the spread of the alarmingly painful and incurable chikungunya virus and dengue fever (a/k/a “break-bone fever”).
“This is essentially using a mosquito as a drug to cure disease,” said Michael Doyle, executive director of the Florida Keys Mosquito Control District, which is waiting to hear if the Food and Drug Administration will allow the experiment, ” reports AP.
However, as Smithsonian Magazine describes it, even putting aside the risk of the genetic modification, this is hardly a perfect solution:
… Read the rest
…Oxitec has focused their efforts on dengue and had some success in small-scale fieldwork in Brazil and the Cayman Islands. And in April 2014, an Oxitec trial led by the Gorgas Institute in Panama released 60,000 genetically modified A.